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Abstract 
Aim: The exact alterations in lipid profile as well as the levels of glycosylated hemoglobin in gestational diabetes are still not 
clearly documented. Methods: To add a new insight to the question, levels of lipid profile parameters and the levels of 
glycosylated hemoglobin were studied in patients with gestational diabetes and compared to controls. Results: Fasting  
plasma  glucose  levels, Plasma  glucose  levels  1 hr and  2 hrs  after  75 gm  oral  glucose  administration (Oral Glucose 
Tolerance Test) were  significantly  higher  in  cases  than  in  controls. Glycosylated hemoglobin was significantly higher in 
cases than in controls. It was observed that there was a significant increase in serum triglycerides in cases with gestational 
diabetes when compared to controls. Conclusion: The results of our study suggests that  abnormal  glucose  levels, 
Glycosylated  hemoglobin  and  serum  triglycerides  plays  an  important  role  in  gestational  diabetes  patients  and  
therefore  extensive  studies  are  required. Early  diagnosis  of  gestational  diabetes  provides  safe  baby  and  motherhood  
and  in  particular  it  will  reduce  the  severity  of  complications  and  mainly  fetal  and  maternal  morbidity  and  mortality. 
Keywords: Lipid profile, Serum cholesterol, Triglycerides, Glycosylated hemoglobin, Oral glucose tolerance test, Gestational 
diabetes  
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Introduction 
Gestational diabetes is the occurrence of diabetes 
in pregnant normal women and is associated with an 
increase incidence of congenital abnormalities when 
compared with normal pregnancy. Frequency of 
congenital malformation in infants of diabetic mothers 
is estimated to be 6-10% (1, 2). Alteration in lipid profile 
is known to occur in diabetic pregnancy (3, 4). 
Oxidative stress due to the damage brought about by 
free radicals is also known to influence the formation of 
anomalies in fetuses born to women with diabetes. 
Moreover, body’s defense mechanisms would play a 
role in the formation of antioxidants and try to minimize 
the damage. Factors responsible for these anomalies 
are not fully understood but there are several reports 
showing that increased free radical production and 
antioxidant depletion in diabetic pregnant women may 
contribute to the formation of anomalies (5). In diabetes 
excess oxygen radicals may result from the auto 
oxidation of glucose (6), and increased level of 
glycated hemoglobin levels, because of increased 
glucose levels in the body (5). There is considerable 
evidence that antioxidant defense system is depleted 
and activity of antioxidant enzymes is reduced in 
diabetes (7). 
In the present study, the following parameters 
were assessed in the serum to elucidate the 
biochemical profile status in patients with gestational 
diabetes. Serum lipid profile parameters, blood glucose 
levels in oral glucose tolerance test and glycosylated 
hemoglobin levels were estimated in patients with 
gestational diabetes and compared to controls.  
 
Materials and Methods 
Selection of Study Subjects 
a. Cases 
25 pregnant  women  with  established  diagnosed  
of  Gestational  diabetes  were  taken  as cases. These  
patients  do  not  have  any  other  complications  
during  pregnancy  such  as  Hypertension, Jaundice, 
Urinary  tract  infections. All the 25 antenatal women 
are in 3rd trimester of pregnancy. 
 
b. Controls 
40 pregnant  women  without  gestational  
diabetes  in 3rd trimester and  without  any  other  
complication  during  pregnancy  are  taken  as  
controls. 
All  the  cases  and  controls  are  selected  
randomly  in  the  age  group  of  16-40  years. All the 
cases and controls are in 3rd trimester only. 
Detailed  history, clinical  examination  and  
obstetric  examination  of  cases  and  controls  
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enrolled  in  this  study  are  carried  out  regarding  any  
current  or  past  history  of  Diabetes, Hypertension, 
Systemic  diseases, any  other  chronic  physical  
disability  and  any  other  obstetrical  complications. 
Informed consent from the cases & controls were 
taken. 
 
Sample collection, processing & storage 
Antecubital  vein, peripheral  vein  of  front  of  
forearm was  selected  for  venous  blood  collection. 
The  arm  was  extended  and  a  tourniquet  was  
applied  a  few  centimeters  above  the  elbow  to  
obstruct  the  venous  return. The  skin  is  sterilized  
over  the  vein  with  a  cotton  swab. A  disposable  
sterile  needle  fixed  to  a  disposable  syringe  of  
10ml  capacity  into  the  vein  is  inserted  which  was  
held  steady  by  thumb. The  plunger  is  withdrawn  
and  as  the  desired  amount  of  blood  was  collected, 
the  tourniquet  was  withdrawn. A  swab  is  placed  
over  the  puncture  site  and  the  needle  is  withdrawn. 
The swab is pressed to arrest the bleeding. The  
needle  is  removed  carefully  avoiding  contamination  
of  fingers  and  slowly  blood  is  transferred  to  an  
appropriate  container. For  separation  of  serum,  
blood  taken  into  a  plain  vial  is  first  allowed  to  clot  
and  then  centrifuged  at  3000  rpm  for  5  minutes. 
This separated serum was used to estimate: 
• Total  cholesterol 
• HDL  cholesterol 
• Triglycerides 
All  specimens  were  clearly  labeled  with  names  
of  cases & controls  along  with  date  and  time  of  
collection. 
Gestational  diabetes  is  a  pregnancy  disorder  
of  human  which  rates  among  one  of  the  causes  
for  maternal & fetal  mortality  and  morbidity. More  
number  of  cases  are  seen  in  developing  countries  
due  to  late  diagnosis  and  inadequate  antenatal  
services. 
The  inspiration  for  this  study  is  to  know  the  
present  morbidity  status  by  analyzing  the  following  
biochemical  parameters. By  estimating  the  levels  of  
these  parameters, we  can  assess  the  ante partum  
severity  of  disease  prognosis  and  outcome  of  
pregnancy. 
The following biochemical parameters were 
estimated in patients with gestational diabetes and 
compared to controls. Oral glucose tolerance test was 
performed by the standard method described by Harold 
varley (8). Glucose was determined using Hitachi 912 
auto analyzer by the standard kit based on the glucose 
oxidase and peroxidase method (9). Glycosylated 
hemoglobin was determined by the method described 
by Little & Goldstein DE (10). Total cholesterol and 
triglycerides were estimated by enzymatic methods (11, 
12). HDL-Cholesterol (HDL-C) was estimated by 
phosphotungstic acid precipitation followed by 
enzymatic analysis in supernatant fraction (13) and 
LDL-Cholesterol (LDL-C) was determined by using 
Friedewald’s equation (14).  
 
Statistical analysis 
Statistical analysis between controls and cases 
was performed by the student t-test using the SPSS 
package. 
 
Results 
The mean + SD of serum lipid profile parameters 
in controls and cases with gestational diabetes were 
shown in Table 1.  
The mean + SD of blood glucose values in oral 
glucose tolerance test (OGTT) in controls and cases 
with gestational diabetes were shown in Table 2. 
The mean + SD of Glycosylated hemoglobin in 
controls and cases with gestational diabetes were 
indicated in the Table 3. 
 
Table 1: The mean ±SD values of serum lipid profile parameters in controls and cases with gestational diabetes 
Parameter            Cases 
Mean ± SD 
         ( n= 25) 
          Controls 
Mean ± SD 
           (n=40) 
        p value 
Serum triglycerides       193.72±9.33       154.15±6.81           <0.001 
Serum Total  cholesterol       179.28±19.28      177.53±18.34           >0.05     
Serum  HDL cholesterol        57.72±7.22        56.00±7.27           >0.05 
Serum  LDL  cholesterol       82.82±19.96        90.70±21.50           >0.05     
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Table 2: The mean ±SD values of Oral Glucose Tolerance Test (OGTT) in controls and cases with gestational diabetes 
 
Table 3: The mean ±SD value of glycosylated hemoglobin in controls and Study subjects (patients) with gestational diabetes 
Parameter            Cases 
Mean ± SD 
         ( n= 25) 
          Controls 
Mean ± SD 
           (n=40) 
        p value 
Glycosylated hemoglobin        8.92±0.47 
 
        7.16±0.47         <0.001 
       
 
Discussion 
We  tried  to  assess  by  our  study  the  
biochemical  profile  in  gestational  diabetes. For  this,  
we  studied plasma  glucose  levels  by  Oral  glucose  
tolerance test, Glycosylated  hemoglobin, Serum  
triglycerides, Serum  total  cholesterol, Serum  HDL  
cholesterol  and  Serum  LDL  cholesterol. We  have  
done  the  comparative  study  of  all  these  
parameters  with  term  matched  control  subjects  and  
cases  of  Gestational  diabetes. Similar reports of 
elevated triglyceride levels in gestational diabetes have 
been reported earlier by Kjos et al (4). In contrast to 
our findings Sobki SH et al reported lower levels of 
triglycerides in patients with gestational diabetes when 
compared to controls (15). 
Fasting  plasma  glucose  levels, Plasma  glucose  
levels  1 hr and  2 hrs  after  75 gm  oral  glucose  
administration (ORAL  GLUCOSE  TOLERANCE  
TEST) are  significantly  higher  in  cases  than  in  
controls. If  the  plasma  glucose  levels  are  higher,  it  
results  in  increased morbidity  to  the  fetus  and  also  
mother. By estimating  this  parameter, we  can  predict  
the  severity  of  the  disease  process  and  can  plan  
to  provide  better  antenatal  care  by  institutional  
treatment  to  save  the  mother  and  the  child  from  
all  the  grave  complications  of  gestational  diabetes. 
Similar reports of elevated blood glucose levels in 
gestational diabetes have been reported earlier by 
Taricco E et al (16).     
Glycosylated  hemoglobin  is  significantly higher  
in  cases  than  in  controls. This  parameter  provides  
the  level  of  blood  glucose  8-12  week  period  prior  
to  determination. So, by estimating  this  parameter , 
we  can  avoid  further  deterioration  of  the  disease  
process  by  early  detection  and  prompt  treatment. 
Significantly elevated levels of glyosylated hemoglobin 
in gestational diabetes were also reported by 
researchers in several studies supporting our 
hypothesis (17, 18). 
By the results of our present study it is evident that 
the serum  triglycerides  were  significantly  elevated  in  
patients with gestational diabetes  than  in controls. So, 
by  estimating  this  parameter,  we  can  supplement  
diet  which  provides  adequate  nutrition  to  both  the 
mother  and  the  fetus  as  well  as  low  in  lipid  
content. Supplementing  such  diet  during  the  
antenatal  period  is  the  better  choice  of treatment  in  
gestational  diabetes  to  reduce  fetal  and  maternal  
morbidity  and  mortality. 
 
Conclusion 
Finally, our  study  show  that  abnormal  glucose  
levels, Glycosylated  hemoglobin  and  serum  
triglycerides  plays  an  important  role  in  gestational  
diabetes  patients  and  therefore  extensive  studies  
are  required. Early  diagnosis  of  gestational  diabetes  
provides  safe  baby  and  motherhood  and  in  
particular  it  will  reduce  the  severity  of  
complications  and  mainly  fetal  and  maternal  
morbidity  and  mortality. 
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